Category Archives: People

Love of the Game Auctions Summer 2026 Premier Auction Underway, Featuring High-Profile Restored ‘Die-Cut’ T206 Honus Wagner

Highlights Will Be on Display at The National in Chicago KINGSTON, N.Y., July 24, 2026 (GLOBE NEWSWIRE) — Love of the Game Auctions’ (LOTG’s) 2026 Summer Premier Auction is now open, running until Saturday, August 8. Featuring the high-profile Restored “Die-Cut” T206 Honus Wagner, the auction has nearly 1,400 lots including rare baseball cards from […]

5th Annual Lake to Lake Paddle Challenge Returns With $7,900 in Prizes

Aug. 22 event offers competitive and adventure divisions on the Shenango River Water Trail in Mercer County, PA Mercer County, PA, July 24, 2026 (GLOBE NEWSWIRE) — VisitMercerCountyPA has opened registration for the 5th Annual Lake to Lake Paddle Challenge, a timed paddling event returning to Mercer County on Aug. 22, 2026, with $7,900 in […]

ARCPOINT PROVIDES LEADERSHIP UPDATE

GREENVILLE, South Carolina, July 24, 2026 (GLOBE NEWSWIRE) — ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) announces today that Peter Kendall has stepped down as Interim Chief Executive Officer of the Company, having completed his mandate and delivered his assessment and recommendations to the Board of Directors. Mr. Kendall was appointed Interim Chief Executive […]

HorseFil Publishes Full Milligram Amounts for All Seven Ingredients: Tongkat Ali 200 mg, Serving Directions, and Safety Information for 2026

HorseFil’s Tongkat Ali, Maca Root, Ashwagandha, and Horny Goat Weed Amounts Per Gummy Ogden, UT, July 24, 2026 (GLOBE NEWSWIRE) — These statements have not been evaluated by the Food and Drug Administration. HorseFil is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use, especially if currently […]

Pelthos Therapeutics Announces 2026 Annual Meeting of Stockholders

DURHAM, N.C., July 24, 2026 (GLOBE NEWSWIRE) — Pelthos Therapeutics Inc. (NYSE American: PTHS) (the “Company” or “Pelthos”) today announced that it will hold its 2026 Annual Meeting of Stockholders virtually on Tuesday, September 29, 2026 at 9:00 a.m. Eastern Time. Stockholders of record as of the close of business on August 4, 2026 are […]

NovaBridge Biosciences to Hold Annual General Meeting on September 8, 2026

ROCKVILLE, Md., July 24, 2026 (GLOBE NEWSWIRE) — NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a clinical-stage biopharmaceutical company advancing innovative medicines for areas of significant unmet need, today announced that it will hold its annual general meeting of shareholders (the “AGM”) at NovaBridge Biosciences Shanghai office, 38F, AIA Tower, No. 866 Dongchangzhi Road, […]

Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Listed Securities Deficiency

Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Listed Securities Deficiency IRVINE, California – July 24, 2026 (GlobeNewswire) – Mdxhealth SA (NASDAQ: MDXH) (the “Company” or “mdxhealth”), a leader in urology-focused precision diagnostics, today announced that the Company received an additional notification letter (the “Additional Letter”) from The Nasdaq Stock Market LLC […]

NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)

– Positive CHMP opinion supports potential commercialization of obicetrapib monotherapy and obicetrapib/ezetimibe fixed-dose combination in Europe – – Recommendation based on positive Phase 3 BROADWAY, BROOKLYN, and TANDEM data – – European Commission decision expected in 2H26 – NAARDEN, The Netherlands and MIAMI and FLORENCE, Italy, July 24, 2026 (GLOBE NEWSWIRE) — NewAmsterdam Pharma Company […]

Amwell® to report second quarter 2026 operating results

BOSTON, July 24, 2026 (GLOBE NEWSWIRE) — Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report second quarter 2026 operating results after stock market trading hours on Tuesday, August 4. Following the distribution of the earnings release via wire services, the Amwell management team will host a live […]

Immutep Announces Abstract Accepted for Presentation at the European Society for Medical Oncology (ESMO) Congress 2026

SYDNEY, AUSTRALIA, July 24, 2026 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a late-stage immunotherapy company targeting cancer and autoimmune diseases, today announced that an abstract for the investigator-initiated EFTISARC-NEO Phase II trial evaluating its first-in-class MHC Class II agonist, eftilagimod alfa (“efti”), has been accepted for presentation at […]